A D S Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Notice is hereby given pursuant ....
Awaiting price reaction for this filing.
A D S Diagnostics Ltd has informed BSE that its Board of Directors will meet on Wednesday, 12 November 2025 at the company's registered office in New Delhi. The main agenda item is to consider and approve the Unaudited Financial Results of the company for the quarter and half year ended 30 September 2025. The meeting notice has been issued under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The letter is signed by N.L. Nayari, who serves as both CFO and Company Secretary. No financial figures or detailed agenda items beyond the results approval are disclosed in this advance notice.
This is a routine compliance filing ahead of the upcoming earnings announcement. Shareholders should watch for the actual Q2/H1 FY26 results on or after 12 November 2025 to assess the company's performance. No immediate material impact on the stock is expected from the notice itself.